EUVIMEDEUVIMED entdecken
Crossref

L26/P-084 Optimizing sperm selection for intrauterine insemination in patients with idiopathic infertility

O. Kocur, P. Xie, L. Ng, G. Palermo, Z. Rosenwaks

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von O. Kocur und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question In couples with idiopathic infertility, does microfluidic sperm selection (MFSS) improve intrauterine insemination (IUI) outcomes and are these effects related to ovarian stimulation protocol? Summary answer MFSS isolates spermatozoa with higher motility and optimized sperm genome, yielding improved pregnancy outcomes in IUI cycles medicated with selective estrogen receptor modulator (SERM). What is known already IUI is a first-line treatment for idiopathic infertility, with density gradient centrifugation (DGC) routinely used for semen preparation. However, DGC is technician-dependent and exposes spermatozoa to silica gel particles and putative oxidative stress, potentially compromising sperm quality especially in patients with a subtle male factor such as elevated sperm chromatin fragmentation (SCF). MFSS is a centrifugation-free technique that enriches highly motile spermatozoa with superior genomic integrity, yet its clinical value in IUI cycles particularly across different ovarian stimulation protocols remains to be investigated. Study design, size, duration In the past 8 years, we included couples with idiopathic infertility undergoing IUI treatment, with maternal age <35 years included to limit confounding female factor. We evaluated semen parameters and SCF on MFSS or DGC-selected samples. Clinical outcomes including biochemical and clinical pregnancies were compared between DGC- and MFSS-IUI cycles according to ovarian superovulation protocol (natural, gonadotropin, or SERM). Participants/materials, setting, methods 746 couples undergoing 1009 MFSS-IUI cycles were compared with 3618 age-matched couples undergoing 8736 DGC-IUI cycles. DGC was performed according to WHO guidelines, and MFSS according to manufacturer protocols. SCF was assessed using TUNEL (normal: ≤15%). Biochemical pregnancy was defined by a serum HCG level of < 5 mIU/ml, and clinical pregnancy rate was defined by the presence of at least one fetal heartbeat. Cycles were categorized based on stimulation protocol (natural vs. gonadotropin vs. SERM). Main results and the role of chance The study population had a mean maternal age of 33.6±2 years and a mean paternal age of 38.6±5 years. Baseline semen parameters were comparable between the DGC and MFSS groups, with no significant differences in ejaculate volume (2.5±1mL vs. 2.4±1mL), sperm concentration (51.8±24 ×106/mL vs. 70.0±34 ×106/mL), and motility (46.6±3% vs. 45.5±4%). Average SCF of the raw specimen was 11.7±10%. DGC yielded a post-processing sperm concentration of 73.0±36 ×106/mL and motility of 90.3±3%, with a modest decrease in SCF (7.1±5%). In contrast, MFSS produced a more selectively enriched sperm population with a lower concentration compared with DGC (42.2±22 ×106/mL; P<0.001), but significantly higher motility (99.0±1%; P<0.001) and markedly reduced SCF (2.5±1%; P<0.01). In natural cycles (n = 1762), clinical pregnancy rates were comparable between DGC (n = 1639) and MFSS (n = 123) at 10.3% and 12.2%, respectively. Similarly, in gonadotropin-stimulated cycles (n = 712), MFSS (n = 246) did not improve outcomes compared with DGC (n = 466), with clinical pregnancy rates of 17.1% and 21.5%, respectively. In contrast, in SERM-stimulated cycles (n = 7271), MFSS (n = 640) was associated with significantly higher biochemical pregnancy rates (21.7% vs. 16.5%, P<0.01) and clinical pregnancy rates (16.7% vs. 12.3%, P<0.01) compared with SERM-IUI cycles using DGC-processed sperm. Limitations, reasons for caution Although MFSS was associated with improved pregnancy outcomes in SERM-stimulated cycles, comparable outcomes between DGC and MFSS in natural and gonadotropin cycles may be due to smaller sample sizes and limited statistical power. Wider implications of the findings MFSS is a centrifugation-free method that enriches highly motile sperm with improved DNA integrity while reducing technician-dependent variability. Improved outcomes in SERM-IUI cycles suggest that sperm quality may play a pivotal role in treatment success and that MFSS could be adopted routinely. Trial registration number No

Zitieren

APA

Kocur, O., Xie, P., Ng, L., Palermo, G., & Rosenwaks, Z. (2026). L26/P-084 Optimizing sperm selection for intrauterine insemination in patients with idiopathic infertility. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.420

Vancouver

Kocur O, Xie P, Ng L, Palermo G, Rosenwaks Z. L26/P-084 Optimizing sperm selection for intrauterine insemination in patients with idiopathic infertility. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.420

BibTeX
@article{Kocur2026,
  author = {Kocur, O. and Xie, P. and Ng, L. and Palermo, G. and Rosenwaks, Z.},
  title = {L26/P-084 Optimizing sperm selection for intrauterine insemination in patients with idiopathic infertility},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.420}
}
Kostenlos starten →